US 11638704
Bicyclic compounds and their use in the treatment of cancer
granted A61KA61K31/404A61K31/41
Quick answer
US patent 11638704 (Bicyclic compounds and their use in the treatment of cancer) held by TEMPEST THERAPEUTICS, INC. expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEMPEST THERAPEUTICS, INC.
- Grant date
- Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/404, A61K31/41, A61K31/416, A61K31/4184